The CD38 Revolution: How Targeted Therapies Are Changing Myeloma Care
The CD38 Revolution: How Targeted Therapies Are Changing Myeloma Care Multiple Myeloma, a type of blood cancer that originates in the plasma cells of the bone marrow, presents a substantial challenge in oncology. However, with advancements in treatment, CD38-directed therapies have emerged as a transformative force in improving prognosis and ove